4597 — Solasia Pharma KK Cashflow Statement
0.000.00%
Last trade - 00:00- ¥9bn
- ¥7bn
- ¥316m
Annual cashflow statement for Solasia Pharma KK, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4,159 | -2,442 | -2,492 | -1,135 | -1,961 |
| Depreciation | |||||
| Non-Cash Items | 843 | 23 | 452 | -5 | 961 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 31 | -549 | -568 | 281 | -228 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2,789 | -2,473 | -2,074 | -359 | -1,033 |
| Capital Expenditures | -171 | -163 | -403 | 0 | -1 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -1 | -15 | — | 1 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -171 | -164 | -418 | 0 | 0 |
| Financing Cash Flow Items | — | -1 | -3 | -1 | -2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,829 | 361 | 2,571 | 275 | 1,180 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,151 | -2,251 | 89 | -77 | 158 |